MAIA Biotechnology, Inc.
MAIA · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $44 | $16 | $33 | $47 |
| - Cash | $10 | $7 | $11 | $11 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $34 | $8 | $22 | $37 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$23 | -$20 | -$16 | -$12 |
| % Margin | – | – | – | – |
| Net Income | -$23 | -$20 | -$16 | -$13 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.05 | -1.49 | -1.7 | -1.18 |
| % Growth | 29.5% | 12.4% | -44.1% | – |
| Operating Cash Flow | -$16 | -$13 | -$12 | -$4 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$16 | -$13 | -$12 | -$4 |